Opportunities and Challenges of Commercializing Biotech Products in Egypt: Bt Maize: A Case Study

Chapter
Part of the Science Policy Reports book series (SCIPOLICY, volume 7)

Abstract

GM technology has been developed to solve the problems of hunger and poverty, and also to create job opportunities and improve the quality of life in developing countries. In agriculture, genetically modified organisms (GMOs) are developed to possess several desirable traits, such as resistance to pests, herbicides, and harsh environmental conditions, improved product shelf life, increased nutritional value, and possession of traits for production of valuable goods such as drugs (pharming). Egypt was one of the few countries to realize in the 1980s the importance of GM crops in achieving sustainable agriculture. Technology transfer and building capacities for the development of agricultural crops through biotechnology started in the early 1990s. In 2008, Egypt approved the cultivation and commercialization of a Bt maize variety, marking the first legal introduction of GM crop into the country. The case of commercialization of Bt maize in Egypt is very unique. It has been 5 years since the first approval for commercialization of this biotech product in Egypt; it is important to discuss the current situation of this biotech product in the Egyptian market and evaluate the benefits for the farmers and the consumers after the adoption of this product. It is also important to highlight the constraints in commercializing this product, and the opportunity for adoption and commercialization of other biotech products in the Egyptian market in the future.

Keywords

Bt maize GM maize GMO Agricultural biotechnology Public–private partnership Egypt 

Abbreviations

EPA

Environmental Protection Agency (USA)

References

  1. Abdallah N (2010) GM crops in Africa: challenges in Egypt. GM Crops and Food 1(3):116–119CrossRefGoogle Scholar
  2. Adenle AA (2011) Adoption of commercial biotech crops in Africa. IPCBEE 7:176–180Google Scholar
  3. Case study No. II. Bt maize. www.whitehouse.gov
  4. Chalony C, Moisseron J (2010) Research governance in Egypt. Sci Technol and Soc 15(2):371–397CrossRefGoogle Scholar
  5. Egypt invests in its science: Latest budget establishes research as a national priority (2011) Nature 474 266. Retrieved from www.nature.com
  6. Elbanna H (2011) Terza Giornata Mondiale Del Mais, Bioenergy, Italy. (CREMONA, 18–20 MARZO 2011), Maize Production in Egypt. Hany Elbanna, Chief Editor of Al-Ahram Agriculture MagazineGoogle Scholar
  7. European Food Safety Authority (2009) Scientific opinion on applications for renewal of authorization for the continued marketing of maize MON810 and existing derived food and feed products. EFSA J 1149:57–85Google Scholar
  8. European Food Safety Authority (2012) Scientific opinion on the annual monitoring report by Monsanto on the cultivation of GM maize MON 810 in 2010. EFSA J 10(4):2610Google Scholar
  9. James C (2010) Global status of commercialized biotech/GM crops. ISAAA Brief No.42. International Service for the Acquisition of Agri-Biotech Applications, IthacaGoogle Scholar
  10. Karembu M, Nguthi F, Ismail H (2009) Biotech crops in Africa: the final frontier. ISAAA AfriCenter, Nairobi, pp 1–34Google Scholar
  11. Krenz RD, El Guindy M, Ariza-Nino E, Siddik I (1999) Utilization of maize in Egypt. Report No.72. Retrieved from http://pdf.usaid.gov/pdf_docs/Pnacs287.pdf
  12. Madkour MA (2000) Egypt: biotechnology from laboratory to the marketplace: challenges and opportunities. In: Persley GJ, Lantin MM (eds) Agriculture biotechnology and the poor: proceedings of an international conference, Washington, DC: 21–29 Oct 2000Google Scholar
  13. Mansour S (2012) Egypt grain and feed annual report, wheat and corn production on the rise (USDA Foreign Agricultural Service). Retrieved from http://gain.fas.usda.gov
  14. Navarro MJ (2009) Communicating crop biotechnology: stories from stakeholders. ISAAA Brief No.40. International Service for the Acquisition of Agri-Biotech Applications, IthacaGoogle Scholar
  15. Obidimma CE, Abdallah SD (2012) Building trust in biotechnology crops in light of the Arab Spring: a case study of Bt maize in Egypt. Agriculture & Food Security, 1(Suppl 1):S4. Retrieved from http://www.agricultureandfoodsecurity.com/content/pdf/2048-7010-1-S1-S4.pdf
  16. Pilcher CD, Rice M, Obrycki J, Lewis L (1997) Field and laboratory evaluation of transgenic Bacillus thuringiensis corn on secondary Lepidopteran pests (Lepidoptera: Noctuidae). J Econ Ent 90:669–678Google Scholar
  17. Review of the Séralini et al (2012) publication on a 2-year rodent feeding study with glyphosate formulations and GM maize NK603 as published online on 19 September 2012 in food and chemical toxicology. EFSA Journal 10(10):2910Google Scholar
  18. Scheufele D (2007) Opinion climates, spirals of silence and biotechnology: public opinion as a heuristic for scientific decision-making. In: Brossard D, Shanahan J, Nesbitt TC (eds) The media, the public and agricultural biotechnology. CAB International, Cambridge, MA, pp 231–244CrossRefGoogle Scholar
  19. Semeada AM, Fédière G, Elkheikh MAK, El-Sherif SI (1999) Current status of corn borers in maize fields and pilot utilization of Sesamia crefica granulovirtis “sscgv”as a biocontrol agent. J Agric Sci Mansoura Univ 24(11):6955–6964Google Scholar
  20. Séralini GE, Claira E, Mesnagea R, Gress S, Defargea N, Malatestab M, Hennequinc D, de Vendômoisa JS (2012) Long term toxicity of a roundup herbicide and a roundup-tolerant genetically modified maize. Food Chem Toxicol 50(11):4221–4231. doi: http://dx.doi.org/10.1016/j.fct.2012.08.005
  21. Soliman M (1994) Corn borers affecting maize in Egypt. In “insect resistant maize, recent advances and utilization”. In: Proceedings of an international symposium, CIMMYT, 27 Nov–3 Dec 1994Google Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  1. 1.Agricultural Genetic Engineering Research InstituteCairo GizaEgypt

Personalised recommendations